Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-07-30

FDA Approved: TEMSIROLIMUS — Original Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved Accord Healthcare's original ANDA for temsirolimus, a generic version of the cancer drug used to treat advanced renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temsirolimus (temsirolimus)

Snippet

ORIG AP for TEMSIROLIMUS (TEMSIROLIMUS)